Optimi Health OPTH
NASDAQ OPTH
$2.25 +0.02 (+0.90%)
At close: Nov 13, 2026 · 4:00 PM EST

Optimi Health (OPTH) EBITDA Margin (2024 - 2026)

Updated

Optimi Health's EBITDA Margin was -2223.44% in the quarter ended Jun 30, 2026, up 717.56 percentage points from the prior quarter.

Analysis

Optimi Health (OPTH) EBITDA Margin (2024 - 2026) Analysis & Trends

On a trailing twelve-month basis, Optimi Health's EBITDA Margin was -3875.21% through Jun 30, 2026, down 2628.77 percentage points year-over-year; for the year ended Sep 30, 2025, it came in at -983.72%, up 342.58 percentage points from the prior year.

  • In earlier years, EBITDA Margin was -1326.30% in the year ended Sep 30, 2024 (+1206.43 pp) and -2532.73% in the year ended Sep 30, 2023.
  • The figure for the quarter ended Jun 30, 2026 marks the highest quarterly EBITDA Margin since the quarter ended Mar 31, 2025.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBITDA Margin (Qtr)
1 Eli Lilly 1,359.75 Bn 1,333.37 Bn 20.46 Bn 36.69%
2 Johnson & Johnson 688.76 Bn 608.62 Bn 17.30 Bn 32.68%
3 AbbVie 521.69 Bn 489.75 Bn 13.12 Bn 46.88%
4 Merck 364.31 Bn 327.31 Bn 13.19 Bn 40.60%
5 Novartis Ag 306.35 Bn 279.93 Bn - -
6 Astrazeneca 285.96 Bn 259.56 Bn 13.26 Bn 39.77%
7 Amgen 251.88 Bn 203.53 Bn 7.58 Bn 46.62%
8 Gilead Sciences 208.59 Bn 183.61 Bn 6.73 Bn 50.63%
9 Pfizer 164.73 Bn 112.38 Bn 12.56 Bn 42.49%
10 Optimi Health 9.67 Mn -791,462.39 112,839.24 -2,223.44%
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -2,223.44%
Mar 31, 2026 -2,941.00%
Mar 31, 2025 -728.93%
Dec 31, 2024 -445.77%
Jun 30, 2024 -1,188.43%
API Access

Optimi Health EBITDA Margin API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=ebitda-margin&ticker=OPTH&period=max&api_key=YOUR_API_KEY